Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
Clinical trial NCT01804842 · COMPLETED
Trial details
- NCT number
- NCT01804842
- Sponsor
- Elcelyx Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.